Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting

• Claire S. Whyte,
• Gael B. Morrow,
• Gael B. Morrow,
• Julia S. Gauer,
• Samantha J. Montague,
• Philip L. R. Nicolson,
• Philip L. R. Nicolson

Affiliations

Claire S. Whyte

Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

Gael B. Morrow

Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

Gael B. Morrow

Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

Julia S. Gauer

Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom

Samantha J. Montague

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

Philip L. R. Nicolson

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

Philip L. R. Nicolson

West Midlands Haemophilia Comprehensive Care Centre, University Hospitals Birmingham Foundation Trust, Birmingham, United Kingdom